Cargando…

Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment

There has been a recent paradigm shift in the way we target cancer, drawing a greater focus on the role of the tumor microenvironment (TME) in cancer development, progression and metastasis. Within the TME, there is a crosstalk in signaling and communication between the malignant cells and the surro...

Descripción completa

Detalles Bibliográficos
Autores principales: Remillard, Taylor C, Bratslavsky, Gennady, Jensen-Taubman, Sandra, Stetler-Stevenson, William G, Bourboulia, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452049/
https://www.ncbi.nlm.nih.gov/pubmed/26056585
http://dx.doi.org/10.1186/2052-8426-2-17
_version_ 1782374240473841664
author Remillard, Taylor C
Bratslavsky, Gennady
Jensen-Taubman, Sandra
Stetler-Stevenson, William G
Bourboulia, Dimitra
author_facet Remillard, Taylor C
Bratslavsky, Gennady
Jensen-Taubman, Sandra
Stetler-Stevenson, William G
Bourboulia, Dimitra
author_sort Remillard, Taylor C
collection PubMed
description There has been a recent paradigm shift in the way we target cancer, drawing a greater focus on the role of the tumor microenvironment (TME) in cancer development, progression and metastasis. Within the TME, there is a crosstalk in signaling and communication between the malignant cells and the surrounding extracellular matrix. Matrix metalloproteinases (MMPs) are zinc-dependent endoproteases that have the ability to degrade the matrix surrounding a tumor and mediate tumor growth, angiogenesis and metastatic disease. Their endogenous inhibitors, the Tissue Inhibitors of Metalloproteinases (TIMPs), primarily function to prevent degradation of the ECM via inhibition of MMPs. However, recent studies demonstrate that TIMP family members also possess MMP-independent functions. One TIMP member in particular, TIMP-2, has many distinct properties and functions, that occur independent of MMP inhibition, including the inhibition of tumor growth and reduction of angiogenesis through decreased endothelial cell proliferation and migration. The MMP-independent molecular mechanisms and signaling pathways elicited by TIMP-2 in the TME are described in this review.
format Online
Article
Text
id pubmed-4452049
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44520492015-06-09 Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment Remillard, Taylor C Bratslavsky, Gennady Jensen-Taubman, Sandra Stetler-Stevenson, William G Bourboulia, Dimitra Mol Cell Ther Review There has been a recent paradigm shift in the way we target cancer, drawing a greater focus on the role of the tumor microenvironment (TME) in cancer development, progression and metastasis. Within the TME, there is a crosstalk in signaling and communication between the malignant cells and the surrounding extracellular matrix. Matrix metalloproteinases (MMPs) are zinc-dependent endoproteases that have the ability to degrade the matrix surrounding a tumor and mediate tumor growth, angiogenesis and metastatic disease. Their endogenous inhibitors, the Tissue Inhibitors of Metalloproteinases (TIMPs), primarily function to prevent degradation of the ECM via inhibition of MMPs. However, recent studies demonstrate that TIMP family members also possess MMP-independent functions. One TIMP member in particular, TIMP-2, has many distinct properties and functions, that occur independent of MMP inhibition, including the inhibition of tumor growth and reduction of angiogenesis through decreased endothelial cell proliferation and migration. The MMP-independent molecular mechanisms and signaling pathways elicited by TIMP-2 in the TME are described in this review. BioMed Central 2014-06-03 /pmc/articles/PMC4452049/ /pubmed/26056585 http://dx.doi.org/10.1186/2052-8426-2-17 Text en © Remillard et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Remillard, Taylor C
Bratslavsky, Gennady
Jensen-Taubman, Sandra
Stetler-Stevenson, William G
Bourboulia, Dimitra
Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title_full Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title_fullStr Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title_full_unstemmed Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title_short Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
title_sort molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452049/
https://www.ncbi.nlm.nih.gov/pubmed/26056585
http://dx.doi.org/10.1186/2052-8426-2-17
work_keys_str_mv AT remillardtaylorc molecularmechanismsoftissueinhibitorofmetalloproteinase2inthetumormicroenvironment
AT bratslavskygennady molecularmechanismsoftissueinhibitorofmetalloproteinase2inthetumormicroenvironment
AT jensentaubmansandra molecularmechanismsoftissueinhibitorofmetalloproteinase2inthetumormicroenvironment
AT stetlerstevensonwilliamg molecularmechanismsoftissueinhibitorofmetalloproteinase2inthetumormicroenvironment
AT bourbouliadimitra molecularmechanismsoftissueinhibitorofmetalloproteinase2inthetumormicroenvironment